Caregiver Support Intervention for Caregiver Stress Syndrome
(TACSI Trial)
Trial Summary
What is the purpose of this trial?
The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.
Do I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medications like antidepressants, anxiolytics, or anti-psychotics, you must have been on a stable dosage for the past three months to participate.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medications (like antidepressants or anti-anxiety drugs), you must have been on a stable dose for the past three months to participate.
What data supports the idea that Caregiver Support Intervention for Caregiver Stress Syndrome is an effective treatment?
The available research shows that caregivers of individuals with traumatic brain injury (TBI) and Alzheimer's disease and related dementias (ADRD) face significant challenges, including psychological stress and social isolation. The studies highlight the need for interventions like the Caregiver Support Intervention to address these issues. While specific data on the effectiveness of this intervention is not provided, the research emphasizes the importance of support for caregivers to improve their well-being and resilience. Compared to other treatments, such as the D'Zurilla and Nezu social problem-solving model, which is noted as beneficial, the Caregiver Support Intervention is suggested to be a necessary approach to help caregivers manage stress and improve their quality of life.12345
What data supports the effectiveness of the treatment TBI-AD/ADRD Caregiver Support Intervention (TACSI) for caregiver stress syndrome?
What safety data exists for the Caregiver Support Intervention for Caregiver Stress Syndrome?
The provided research does not directly address safety data for the Caregiver Support Intervention for Caregiver Stress Syndrome or its variants like TACSI. The studies focus on the challenges and needs of caregivers for individuals with TBI and ADRD, the effectiveness of remote interventions, and the impact of caregiving. However, they do not provide specific safety data for the intervention itself.13678
Is the treatment TACSI a promising treatment for caregiver stress syndrome?
Yes, TACSI is a promising treatment because it focuses on supporting caregivers of people with traumatic brain injury and Alzheimer's disease. It aims to reduce stress, improve psychological well-being, and provide necessary support and education to caregivers, which are crucial for their health and the care they provide.13568
How is the TACSI treatment different from other treatments for caregiver stress syndrome?
The TACSI treatment is unique because it focuses on providing comprehensive support for caregivers of individuals with traumatic brain injury (TBI) and Alzheimer's disease-related dementias (ADRD), addressing both cognitive and behavioral symptom management and care coordination. Unlike other treatments, it emphasizes interdisciplinary care and support for caregivers, aiming to improve outcomes for both the patients and their caregivers.13568
Eligibility Criteria
This trial is for caregivers over 21 years old in the U.S. who primarily assist a family member with both traumatic brain injury and dementia, are English-speaking, willing to participate, and not receiving similar psychosocial support elsewhere. Caregivers must be stable on any psychotropic medications for three months.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporating psychosocial and psychoeducational approaches
Follow-up
Participants are monitored for changes in caregiver primary subjective stress
Extended Follow-up
Participants are further monitored for changes in caregiver primary subjective stress
Treatment Details
Interventions
- TBI-AD/ADRD Caregiver Support Intervention (TACSI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
Minneapolis Veterans Affairs Medical Center
Collaborator
Mayo Clinic
Collaborator
United States Department of Defense
Collaborator